MRRPhysical AI
intelligence
← Company intelligence

Robot maker · early

AiM Medical Robotics

Corporate marketmedicalCurated record
aimmedicalrobotics.com

Portable MRI-compatible neurosurgical robot designed for intraoperative use inside MRI suites and operating rooms; targets functional brain disorders (Parkinson's disease, epilepsy) and cancer neurosurgery; vendor claims up to 50% procedure time reduction via precision automation; first human clinical study initiated at Brigham and Women's Hospital (WPI spinout, co-founded by Gregory Fischer and Julie Pilitsis).

HeadquartersWorcester, US
Founded2018
Corporate funding$23M
Team11-50
Deployments1
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A
FoundersGregory Fischer, PhD (Co-Founder & CEO, WPI Professor of Robotics Engineering), Julie G. Pilitsis, MD, PhD, MBA (Co-Founder, Chair of Neurosurgery University of Arizona)
Regions servedNorth America
Countries deployedNot listed
Service footprintMRI-compatible neurosurgical robotics; clinical studies in the US (Brigham and Women's Hospital); WPI-affiliated spinout targeting Parkinson's, epilepsy, and cancer neurosurgery
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

MRI-Compatible Neurosurgical Robot

  • Portable, MRI-compatible design for intraoperative use in both MRI suites and conventional operating rooms; targets functional brain disorders (Parkinson's, epilepsy) and neurosurgical oncology

    Vendor-stated MRI compatibility and use-case scope of the investigational neurosurgical robot

    Claim source
  • Claimed up to 50% reduction in procedure time

    Vendor-stated expected efficiency gain vs. conventional neurosurgical workflow

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2024-05-01Brigham and Women's HospitalNot listedNot listedNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordIQ CapitalSurrey Capital PartnersSontag Foundation
TL

Company timeline

Milestones and announcements

2025-09-01Closed $8.1M Series A; first human clinical study initiated at Brigham and Women's HospitalAiM Medical Robotics
2022-06-01Received Sontag Foundation Innovation Fund grant supporting pre-clinical developmentAiM Medical Robotics
2022-03-01Closed $3.4M seed round backed by IQ Capital and Surrey Capital PartnersAiM Medical Robotics
SC

Source ledger

7 unique public sources

01
AiM Medical Robotics Secures $8.1 Million Series A Financing to Transform Neurosurgery with MRI-Compatible Surgical RoboticsGlobeNewswire · retrieved 2026-07-05
02
SEC Form D: $6,740,904 sold of $10,803,904 offeringSEC EDGAR · retrieved 2026-07-05
03
SEC Form D: $1,587,500 sold of $2,500,000 offeringSEC EDGAR · retrieved 2026-07-05
04
AiM Medical Robotics – Precision Neurosurgical RoboticsAiM Medical Robotics · retrieved 2026-07-05
05
AiM Medical Robotics Raises $3.4M in Seed Financing to Advance Neurosurgery with MRI-Compatible RoboticsPR Newswire · retrieved 2026-07-05
06
SEC Form D: $3,364,723 sold of $3,700,000 offeringSEC EDGAR · retrieved 2026-07-05
07
AiM Medical Robotics raises $8.1M for MRI-compatible surgical roboticsMassDevice · retrieved 2026-07-05